These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 11553682)

  • 1. Specific proteolysis of the NR2 subunit at multiple sites by calpain.
    Guttmann RP; Baker DL; Seifert KM; Cohen AS; Coulter DA; Lynch DR
    J Neurochem; 2001 Sep; 78(5):1083-93. PubMed ID: 11553682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ.
    Guttmann RP; Sokol S; Baker DL; Simpkins KL; Dong Y; Lynch DR
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1023-30. PubMed ID: 12183659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtype-dependence of NMDA receptor channel open probability.
    Chen N; Luo T; Raymond LA
    J Neurosci; 1999 Aug; 19(16):6844-54. PubMed ID: 10436042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptor.
    Dong YN; Waxman EA; Lynch DR
    J Neurosci; 2004 Dec; 24(49):11035-45. PubMed ID: 15590920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.
    Bresink I; Benke TA; Collett VJ; Seal AJ; Parsons CG; Henley JM; Collingridge GL
    Br J Pharmacol; 1996 Sep; 119(2):195-204. PubMed ID: 8886398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subunit-specific effects of poricoic acid A on NMDA receptors.
    Lee J; Kim C; Yeom HD; Nguyen KVA; Eom S; Lee S; Jung JH; Lee JH; Kim SH; Kim IK; Lee JH
    Pharmacol Rep; 2020 Apr; 72(2):472-480. PubMed ID: 32048268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inducible expression and pharmacological characterization of recombinant rat NR1a/NR2A NMDA receptors.
    Kurkó D; Dezso P; Boros A; Kolok S; Fodor L; Nagy J; Szombathelyi Z
    Neurochem Int; 2005 Apr; 46(5):369-79. PubMed ID: 15737435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological heterogeneity of NMDA receptors: characterization of NR1a/NR2D heteromers expressed in Xenopus oocytes.
    Buller AL; Monaghan DT
    Eur J Pharmacol; 1997 Feb; 320(1):87-94. PubMed ID: 9049607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterisation of stable cell lines expressing recombinant human N-methyl-D-aspartate receptor subtypes.
    Grimwood S; Le Bourdellès B; Atack JR; Barton C; Cockett W; Cook SM; Gilbert E; Hutson PH; McKernan RM; Myers J; Ragan CI; Wingrove PB; Whiting PJ
    J Neurochem; 1996 Jun; 66(6):2239-47. PubMed ID: 8632144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amino acid residue at sequence position 5 in the conantokin peptides partially governs subunit-selective antagonism of recombinant N-methyl-D-aspartate receptors.
    Klein RC; Prorok M; Galdzicki Z; Castellino FJ
    J Biol Chem; 2001 Jul; 276(29):26860-7. PubMed ID: 11335724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and pharmacological characterization of recombinant rat/mice N-methyl-D-aspartate receptor subtypes in the yeast Saccharomyces cerevisiae.
    Becker J; Li Z; Noe CR
    Eur J Biochem; 1998 Sep; 256(2):427-35. PubMed ID: 9760184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of glutamate binding sites in receptors assembled from transfected NMDA receptor subunits.
    Kendrick SJ; Lynch DR; Pritchett DB
    J Neurochem; 1996 Aug; 67(2):608-16. PubMed ID: 8764586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activation induced cleavage of the NR2B subunit by calpain.
    Simpkins KL; Guttmann RP; Dong Y; Chen Z; Sokol S; Neumar RW; Lynch DR
    J Neurosci; 2003 Dec; 23(36):11322-31. PubMed ID: 14672996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the effects of polyamines on [125I]MK-801 binding to recombinant N-methyl-D-aspartate receptors.
    Sharma TA; Reynolds IJ
    J Pharmacol Exp Ther; 1999 May; 289(2):1041-7. PubMed ID: 10215685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of NMDA and non-NMDA receptors to in vivo glutamate-induced calpain activation in the rat striatum. Relation to neuronal damage.
    Del Río P; Montiel T; Massieu L
    Neurochem Res; 2008 Aug; 33(8):1475-83. PubMed ID: 18270815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetically modified mouse model probing the selective action of ifenprodil at the N-methyl-D-aspartate type 2B receptor.
    Rosahl TW; Wingrove PB; Hunt V; Fradley RL; Lawrence JM; Heavens RP; Treacey P; Usala M; Macaulay A; Bonnert TP; Whiting PJ; Wafford KA
    Mol Cell Neurosci; 2006 Sep; 33(1):47-56. PubMed ID: 16870468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute and chronic ethanol exposure on heteromeric N-methyl-D-aspartate receptors expressed in HEK 293 cells.
    Blevins T; Mirshahi T; Chandler LJ; Woodward JJ
    J Neurochem; 1997 Dec; 69(6):2345-54. PubMed ID: 9375665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fyn-mediated phosphorylation of NR2B Tyr-1336 controls calpain-mediated NR2B cleavage in neurons and heterologous systems.
    Wu HY; Hsu FC; Gleichman AJ; Baconguis I; Coulter DA; Lynch DR
    J Biol Chem; 2007 Jul; 282(28):20075-87. PubMed ID: 17526495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental and cell-selective variations in N-methyl-D-aspartate receptor degradation by calpain.
    Dong YN; Wu HY; Hsu FC; Coulter DA; Lynch DR
    J Neurochem; 2006 Oct; 99(1):206-17. PubMed ID: 16899064
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subtype-selective antagonism of N-methyl-D-aspartate receptor ion channels by synthetic conantokin peptides.
    Sheng Z; Dai Q; Prorok M; Castellino FJ
    Neuropharmacology; 2007 Jul; 53(1):145-56. PubMed ID: 17588620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.